Psychiatry and Neurology, Neurology · Memphis, TN
NPI
1255659009
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
6029 Walnut Grove Rd Ste 210
Memphis, TN, 38120
Phone (901) 226-4910
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
52,437 services
Medicare patients, 2024
906
Average age 75
Drug cost, 2024
$804K
2,689 prescriptions
Company payments, 2025
$1,470
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pawan V Rawal was code J1576 (injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg), 18,100 times for 36 patients. In total Pawan V Rawal billed 52,437 services in 66 codes, and Medicare paid $3.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 18,100 | 36 | $52.75 | $955K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 7,180 | 14 | $35.90 | $258K |
| 99232 Hospital E&M - Subsequent | Facility | 3,763 | 640 | $57.47 | $216K |
| 96366 Intravenous Infusion, Hydration | Office | 508 | 38 | $14.59 | $7,412 |
| 99222 Hospital E&M - Initial | Facility | 422 | 391 | $94.75 | $40K |
| 99214 Office E&M - Established | Office | 372 | 176 | $77.72 | $29K |
| 96365 Intravenous Infusion, Hydration | Office | 294 | 40 | $43.99 | $13K |
| 95816 Neurologic | Facility | 288 | 277 | $41.08 | $12K |
| 95720 Neurologic | Facility | 284 | 116 | $148.99 | $42K |
| 96375 Injection Administration | Office | 259 | 32 | $10.90 | $2,822 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 216 | 30 | $0.65 | $140 |
| 99223 Hospital E&M - Initial | Facility | 203 | 198 | $126.38 | $26K |
| 99233 Hospital E&M - Subsequent | Facility | 149 | 113 | $86.46 | $13K |
| 95718 Neurologic | Facility | 134 | 100 | $96.35 | $13K |
| 95886 Electrical Nerve Conductivity | Office | 109 | 44 | $64.22 | $7,000 |
By year: 2022 $1.4M for 28,743 services; 2023 $2.0M for 37,112 services; 2024 $3.2M for 52,437 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 40 | 37 | $8.65 | $346 |
Medicare prescription drug claims, 2024
In 2024, the drug Pawan V Rawal prescribed most often to Medicare patients was Levetiracetam, with 299 prescriptions and refills. In total Pawan V Rawal wrote 2,689 Medicare prescriptions that cost $804K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 299 | 541 | 73 | $10K |
| Lamotrigine Generic | 193 | 308 | 33 | $3,896 |
| Lacosamide Generic | 170 | 220 | 26 | $10K |
| Gabapentin Generic | 137 | 207 | 40 | $1,835 |
| Clobazam Generic | 125 | 125 | 14 | $7,355 |
| Topiramate Generic | 116 | 164 | 25 | $1,027 |
| Donepezil Hcl Generic | 109 | 284 | 43 | $1,148 |
| Nortriptyline Hcl Generic | 94 | 137 | 22 | $737 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 67 | 108 | 14 | $981 |
| Pregabalin Generic | 57 | 61 | 21 | $436 |
| Duloxetine Hcl Generic | 56 | 114 | 21 | $976 |
| Zonisamide Generic | 52 | 76 | Under 11 | $2,089 |
| Divalproex Sodium Generic | 49 | 80 | Under 11 | $1,356 |
| Nurtec Odt Rimegepant Sulfate | 48 | 49 | Under 11 | $72K |
| Ubrelvy Ubrogepant | 46 | 46 | Under 11 | $46K |
Brand drugs: - claims; generic drugs: 2,327 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pawan V Rawal $1,470 ($1,470 in general payments such as food, travel and fees) from 23 companies. The largest payer was UCB, Inc. with $251.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 14 | $251 |
| Pfizer Inc. PFE | 16 | $209 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $116 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $94.37 |
| Abbvie Inc. ABBV | 4 | $82.16 |
| Amgen Inc. AMGN | 4 | $78.25 |
| TG Therapeutics, Inc. TGTX | 3 | $75.94 |
| Lundbeck LLC | 3 | $74.06 |
| Lilly USA, LLC LLY | 3 | $52.06 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $49.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.